Stay updated on Nivolumab vs Placebo in Preventing Melanoma Recurrence Clinical Trial

Sign up to get notified when there's something new on the Nivolumab vs Placebo in Preventing Melanoma Recurrence Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab vs Placebo in Preventing Melanoma Recurrence Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page history shows a new revision entry v3.3.2 added and v3.3.1 removed, indicating a minor administrative update to the site's revision history. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T17:51:01.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The study record history now includes a new revision entry v3.3.1 and removes the previous revision v3.2.0.
    Difference
    0.0%
    Check dated 2025-11-24T14:46:36.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The page removed a government funding notice about potential delays in updates and directing users to opm.gov for operating status. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T06:54:54.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    The study record history now includes a new version entry with updates to study status and contact/location information.
    Difference
    0.0%
    Check dated 2025-11-03T01:17:47.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    Summary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.
    Difference
    9%
    Check dated 2025-10-05T10:08:20.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    - Updated revision tag from v3.0.2 to v3.1.0, signaling a new software release. - No other content changes are evident in the provided additions/deletions.
    Difference
    0.2%
    Check dated 2025-09-28T03:16:51.000Z thumbnail image

Stay in the know with updates to Nivolumab vs Placebo in Preventing Melanoma Recurrence Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Placebo in Preventing Melanoma Recurrence Clinical Trial page.